CDTX logo

Cidara Therapeutics, Inc. (CDTX)

Profile

Full Name

Cidara Therapeutics, Inc.

Ticker

NASDAQ: CDTX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

April 15, 2015

Indexes

Not included

Website

https://www.cidara.com

Employees

38

Key Details

Price

$64.85(+0.22%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$1.27M(-94.52% YoY)

Annual EPS

-$26.75(-409.52% YoY)

PE ratio

-

Next earnings date

Nov 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $64.85
    CDTX price is $64.85

    30-Day Relative Volume

    1.19
    CDTX 30-day relative volume is 1.19

    Price Performance

    Price Most recent change

    +0.22%
    CDTX price was up +0.22% on Sep 17, 2025

    Price YTD change

    +141.26%
    CDTX price is up +141.26% since January 1st

    Price 1-year change

    +457.61%
    CDTX price is up +457.61% year-on-year

    Price 3-year change

    +302.3%
    CDTX price is up +302.3% over the past 3 years

    Price Range

    Price All-time high

    $382.60
    CDTX price is currently -83.05% below its historical high of $382.60

    Price 3-year low

    $9.20
    CDTX price is currently +604.89% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $1.64B
    CDTX market capitalization is $1.64 billion

    Market cap 3-year change

    +2811.54%
    CDTX market capitalization is up +2811.54% over the past 3 years

    Market cap All-time high

    $1.71B
    CDTX market capitalization is currently -3.91% below its historical high of $1.71 billion

    Market cap sector rank

    78.86%
    CDTX market capitalization is higher than 78.86% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +260.29%
    CDTX shares outstanding is up +260.29% year-on-year

    Shares Outstanding 3-Year Change

    +623.73%
    CDTX shares outstanding is up +623.73% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.05
    CDTX beta is 1.05

    200-day SMA

    $33.36
    CDTX price is currently +94.38% above its 200-day simple moving average

    50-day SMA

    $61.92
    CDTX price is currently +4.74% above its 50-day simple moving average

    RSI

    54.44
    CDTX 14-day relative strength index is 54.44

    Volume

    1.19
    CDTX 30-day relative volume is 1.19

    ATR

    $3.46
    CDTX average true range is $3.46

    10-day Historical Volatility

    32.77%
    CDTX 10-day historical volatility is 32.77%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $1.27M
    CDTX annual revenue is $1.27 million

    Revenue Analysts estimate

    -
    CDTX annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -94.52%
    CDTX annual revenue is down -94.52% year-on-year

    Revenue Sector rank

    37.85%
    CDTX annual revenue is higher than 37.85% of companies in Healthcare sector

    EPS

    EPS

    -$26.75
    CDTX annual earnings per share is -$26.75

    EPS Analysts estimate

    -$6.01
    CDTX annual earnings per share is currently +344.72% higher than the consensus analysts' forecast

    EPS 1-year change

    -409.52%
    CDTX annual earnings per share is down -409.52% year-on-year

    EPS Sector rank

    6.38%
    CDTX annual earnings per share is higher than 6.38% of companies in Healthcare sector

    Profit

    Gross profit

    $1.04M
    CDTX annual gross profit is $1.04 million

    Gross margin

    81.73%
    CDTX annual gross profit margin is 81.73%

    Operating profit

    -$176.10M
    CDTX annual operating income is -$176.10 million

    Operating margin

    -7154.43%
    CDTX annual operating profit margin is -7154.43%

    Net income

    -$170.29M
    CDTX annual net profit is -$170.29 million

    Net margin

    -13.36K%
    CDTX annual net profit margin is -13.36 thousand%

    Expenses

    Total expenses

    $177.38M
    CDTX annual total expenses is $177.38 million

    Operating expenses

    $177.38M
    CDTX annual total operating expenses is $177.38 million

    Cost of goods sold

    $233.00K
    CDTX annual cost of goods sold is $233.00 thousand

    Selling, general & administrative expenses

    $20.61M
    CDTX annual SGA is $20.61 million

    Depreciation and amortization

    $233.00K
    CDTX annual depreciation & amortization is $233.00 thousand

    Interest expense

    $0.00
    CDTX annual interest expense is $0.00

    Income tax

    $0.00
    CDTX annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$176.10M
    CDTX annual earnings before interest & taxes is -$176.10 million

    EBITDA

    -$175.87M
    CDTX annual EBITDA is -$175.87 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $215.58M
    CDTX annual total assets is $215.58 million

    Non current assets

    $4.06M
    CDTX annual long term assets is $4.06 million

    Current assets

    $210.74M
    CDTX annual total current assets is $210.74 million

    Cash and cash equivalents

    $189.82M
    CDTX annual cash & cash equivalents is $189.82 million

    Accounts receivable

    $1.69M
    CDTX annual accounts receivable is $1.69 million

    Inventory

    $0.00
    CDTX annual inventory is $0.00

    Liabilities

    Total liabilities

    $52.27M
    CDTX annual total liabilities is $52.27 million

    Long term liabilities

    $1.93M
    CDTX annual total long term liabilities is $1.93 million

    Current liabilities

    $49.55M
    CDTX annual total current liabilities is $49.55 million

    Accounts payable

    $3.61M
    CDTX annual accounts payable is $3.61 million

    Debt

    Total debt

    $3.58M
    CDTX annual total debt is $3.58 million

    Total debt 1-year change

    -26.68%
    CDTX annual total debt is down -26.68% year-on-year

    Long term debt

    $1.93M
    CDTX annual long term debt is $1.93 million

    Short term debt

    $1.64M
    CDTX annual short term debt is $1.64 million

    Equity & Capital

    Shareholders equity

    $163.31M
    CDTX annual stockholders equity is $163.31 million

    Book value

    $163.31M
    CDTX annual book value is $163.31 million

    Retained earnings

    -$611.26M
    CDTX annual retained earnings is -$611.26 million

    Working capital

    $161.18M
    CDTX annual working capital is $161.18 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$176.53M
    CDTX annual cash flow from operations is -$176.53 million

    Cash from operations 1-year change

    -686.97%
    CDTX annual cash flow from operations is down -686.97% year-on-year

    Cash from investing

    -$129.00K
    CDTX annual cash flow from investing activities is -$129.00 thousand

    Cash from investing 1-year change

    +74.46%
    CDTX annual cash flow from investing activities is up +74.46% year-on-year

    Cash from financing

    $337.06M
    CDTX annual cash flow from financing activities is $337.06 million

    Cash from financing 1-year change

    +1197.19%
    CDTX annual cash flow from financing activities is up +1197.19% year-on-year

    CAPEX

    CAPEX

    $129.00K
    CDTX annual capital expenditures is $129.00 thousand

    CAPEX 1-year change

    -74.46%
    CDTX annual capital expenditures is down -74.46% year-on-year

    Free Cash Flow

    Free cash flow

    -$176.66M
    CDTX annual free cash flow is -$176.66 million

    Free cash flow 1-year change

    -670.21%
    CDTX annual free cash flow is down -670.21% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    81.73%
    CDTX annual gross profit margin is 81.73%

    Operating margin

    -7154.43%
    CDTX annual operating profit margin is -7154.43%

    Net margin

    -13.36K%
    CDTX annual net profit margin is -13.36 thousand%

    ROA & ROE

    ROA

    -119.88%
    CDTX annual return on assets is -119.88%

    ROE

    -219.59%
    CDTX annual return on equity is -219.59%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    CDTX price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    CDTX price to earnings ratio is unknown

    PB Ratio

    PB ratio

    3.28
    CDTX price to book ratio is 3.28

    PB ratio Sector rank

    68.12%
    CDTX price to book ratio is higher than 68.12% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    CDTX price to sales ratio value is unknown

    PS ratio Sector rank

    -
    CDTX price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $1.13B
    CDTX enterprise value is $1.13 billion

    Enterprise value Sector rank

    74.79%
    CDTX enterprise value is higher than 74.79% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -9.11
    CDTX EV/EBITDA is -9.11

    EV/EBITDA Sector rank

    14.62%
    CDTX EV/EBITDA is higher than 14.62% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    4.25
    CDTX annual current ratio is 4.25

    Quick ratio

    4.25
    CDTX annual quick ratio is 4.25

    Leverage

    Debt to equity

    0.02
    CDTX annual debt to equity ratio is 0.02

    Interest coverage ratio

    -
    CDTX annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    CDTX piotroski f-score value is unknown

    Altman Z-Score

    13.11
    CDTX altman z-score is 13.11

    Analyst ratings

    Recent major analysts updates

    Aug 8, 25 Needham
    Buy
    Aug 8, 25 JMP Securities
    Market Outperform
    Aug 8, 25 HC Wainwright & Co.
    Buy
    Jun 30, 25 JMP Securities
    Market Outperform
    Jun 24, 25 RBC Capital
    Outperform
    Jun 24, 25 HC Wainwright & Co.
    Buy
    Jun 24, 25 Guggenheim
    Buy
    Jun 23, 25 WBB Securities
    Strong Buy
    Jun 23, 25 Needham
    Buy
    Jun 10, 25 Cantor Fitzgerald
    Overweight

    Institutional Ownership

    Screeners with CDTX included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Cidara Therapeutics, Inc.?
    • Does Cidara Therapeutics, Inc. pay dividends?
    • What sector is Cidara Therapeutics, Inc. in?
    • What industry is Cidara Therapeutics, Inc. in?
    • What country is Cidara Therapeutics, Inc. based in?
    • When did Cidara Therapeutics, Inc. go public?
    • Is Cidara Therapeutics, Inc. in the S&P 500?
    • Is Cidara Therapeutics, Inc. in the NASDAQ 100?
    • Is Cidara Therapeutics, Inc. in the Dow Jones?
    • When was Cidara Therapeutics, Inc.'s last earnings report?
    • When does Cidara Therapeutics, Inc. report earnings?

    What is the ticker symbol for Cidara Therapeutics, Inc.?

    The ticker symbol for Cidara Therapeutics, Inc. is NASDAQ:CDTX

    Does Cidara Therapeutics, Inc. pay dividends?

    No, Cidara Therapeutics, Inc. does not pay dividends

    What sector is Cidara Therapeutics, Inc. in?

    Cidara Therapeutics, Inc. is in the Healthcare sector

    What industry is Cidara Therapeutics, Inc. in?

    Cidara Therapeutics, Inc. is in the Biotechnology industry

    What country is Cidara Therapeutics, Inc. based in?

    Cidara Therapeutics, Inc. is headquartered in United States

    When did Cidara Therapeutics, Inc. go public?

    Cidara Therapeutics, Inc.'s initial public offering (IPO) was on April 15, 2015

    Is Cidara Therapeutics, Inc. in the S&P 500?

    No, Cidara Therapeutics, Inc. is not included in the S&P 500 index

    Is Cidara Therapeutics, Inc. in the NASDAQ 100?

    No, Cidara Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Cidara Therapeutics, Inc. in the Dow Jones?

    No, Cidara Therapeutics, Inc. is not included in the Dow Jones index

    When was Cidara Therapeutics, Inc.'s last earnings report?

    Cidara Therapeutics, Inc.'s most recent earnings report was on August 7, 2025

    When does Cidara Therapeutics, Inc. report earnings?

    The next expected earnings date for Cidara Therapeutics, Inc. is November 6, 2025
    On this page